ghk-cu study 2025 news Neurogan Health Copper Peptide, 120 mcg, 60 Tablets : Target GHK-Cu: The Peptide That Transforms

It is sold as a research peptide for laboratory investigation only and is not an approved veterinary medicine

Initial short-term outcomes of CA for AWE published in 2014 have shown promising safety and efficacy profiles, confirmed by subsequent mid- and long-term studies that indicate significant and sustained pain reduction [8, 12]

However, many providers remain reluctant to diagnose endometriosis without surgical confirmation (Practice Committee of the American Society for Reproductive Medicine, 2014)

Oral administration allows the peptide to interact directly with the gastrointestinal lining, targeting areas of injury and promoting mucosal repair, angiogenesis, and barrier strengthening